Dr Marc Teichmann is a neurologist specializing in language disorders. He works at Pitié Salpêtrière, in the Department of Neurology, within the Institute for Memory and Alzheimer’s Disease (IM2A) headed by Prof. Bruno Dubois. He is also Principal Investigator of the ICM-INSERM U1127 laboratory, Frontlab team.His research focuses on semantic dementias (diseases related to Alzheimer’s) and he has directed numerous research protocols including in particular the use of tDCS (transcranial stimulation by direct current) to improve the language performance of patients.
The Foundation is currently supporting his new clinical research project on the restoration of language functions through transcranial stimulation (tDCS).This project aims to test the effects of tDCS on speech disorders in 60 patients. Neuroimaging and neurophysiology techniques will provide a better understanding of the mechanisms supporting the observed improvement.
Recent publications :
- Alzheimer’s Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports, JAD, 2017 https://www.ncbi.nlm.nih.gov/
- Free and Cued Selective Reminding Test – accuracy for the differential diagnosis of Alzheimer’s and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD), Alzheimers Dement. 2017 https://www.ncbi.nlm.nih.gov/
- Direct current stimulation over the anterior temporal areas boosts semantic processing in primary progressive aphasia, Ann Neurol. 2016 https://www.ncbi.nlm.nih.gov/